Prescription drug · ANDA
Quinapril NDC 71335-1134
Quinapril hydrochloride 10 mg/1 · Tablet · Oral · Bryant Ranch Prepack
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71335-1134-1 | 71335113401 | 30 TABLET in 1 BOTTLE (71335-1134-1)Marketed from Nov 8, 2019 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Quinapril
- Generic name (nonproprietary)
- quinapril
- Active ingredients
- Quinapril hydrochloride — 10 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Bryant Ranch Prepack
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 205823
- Marketing start
- Listing expires
- Other FDA classes
- Angiotensin-converting Enzyme Inhibitors (Mechanism)
- Identifiers
- Product ID 71335-1134_fda04907-70de-68d6-e053-6394a90a00d6SPL ID fda04907-70de-68d6-e053-6394a90a00d6SPL set ID fb069caa-14d0-4f76-b662-6145fb4cc276RxCUI 312748UNII 33067B3N2M
- Pharmacologic class
- Angiotensin Converting Enzyme Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471335113401followed by a unit qualifier and the quantityPackage 71335-1134-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Hypertension Quinapril tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. There are no controlled trials demonstrating risk reduction with quinapril tablets. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic th…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 205823
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Quinapril | Quinapril hydrochloride 10 mg/1 | TabletOral | Proficient Rx LP | 71205-484 |
| Quinapril | Quinapril hydrochloride 20 mg/1 | TabletOral | Bryant Ranch Prepack | 63629-8710 |
| Quinapril | Quinapril hydrochloride 5 mg/1 | TabletOral | Solco Healthcare US, LLC | 43547-410 |
| Quinapril | Quinapril hydrochloride 40 mg/1 | TabletOral | Solco Healthcare US, LLC | 43547-413 |
| Quinapril | Quinapril hydrochloride 10 mg/1 | TabletOral | Solco Healthcare US, LLC | 43547-411 |
| Quinapril | Quinapril hydrochloride 20 mg/1 | TabletOral | Solco Healthcare US, LLC | 43547-412 |